Kemnay Advisory Services’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
RI
PAI
Kemnay Advisory Services's ACAD Position: Q2 2026 in Review
Kemnay Advisory Services increased its Acadia Pharmaceuticals (ACAD) stake by 10% in Q2 2026, buying an estimated $2.33K and bringing the position to 1,158 shares worth $29.3K. The position accounts for ﹤0.01% of the portfolio, ranked #510.
Kemnay Advisory Services first reported a position in ACAD in Q4 2025 and has held it in 3 quarters since. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.
- Kemnay Advisory Services held 1,158 shares of Acadia Pharmaceuticals worth $29.3K as of Q2 2026.
- Kemnay Advisory Services bought 106 Acadia Pharmaceuticals shares in Q2 2026, an estimated $2.33K.
- Acadia Pharmaceuticals made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #510 holding.
- Kemnay Advisory Services first reported a position in Acadia Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.